Published in Cancer Epidemiol Biomarkers Prev on January 01, 1998
Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore. J Med Chem (2010) 2.12
Structural Characterization, Biological Effects, and Synthetic Studies on Xanthones from Mangosteen (Garcinia mangostana), a Popular Botanical Dietary Supplement. Mini Rev Org Chem (2008) 1.01
Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women. J Carcinog (2006) 0.88
Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prev Res (Phila) (2013) 0.86
17α-ethynyl-5α-androstane-3α, 17β-diol treatment of MNU-induced mammary cancer in rats. Int J Breast Cancer (2011) 0.80
Non steroidal anti-inflammatory drug use and levels of oestrogens and androgens in men. Clin Endocrinol (Oxf) (2012) 0.75
I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther (2009) 5.01
Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline. J Exp Med (1970) 4.49
Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med (1974) 3.64
A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc Natl Acad Sci U S A (1996) 3.43
Genetics of immunoglobulins in the mouse. Adv Immunol (1967) 3.14
The locomotion of mouse fibroblasts in tissue culture. Biophys J (1970) 2.75
H-2-linked immune response (Ir) genes. Independent loci for Ir-IgG and Ir-IgA genes. J Exp Med (1972) 2.50
A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody. J Immunol (1981) 2.27
Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med (1977) 2.18
Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res (1999) 2.13
Association of H-2 types with genetic control of immune responsiveness to IgA allotypes in the mouse. Proc Natl Acad Sci U S A (1971) 2.07
The perception of heading during eye movements. Nature (1992) 2.06
Choroid plexus cysts: not associated with Down syndrome. Ultrasound Obstet Gynecol (1996) 2.02
Effect of colcemid on fibroblast motility. Exp Cell Res (1971) 2.01
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res (2000) 1.96
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog (1999) 1.95
Clonal nature of the immune response to phosphorylcholine. II. Idiotypic specificity and binding characteristics of anti-phosphorylcholine antibodies. J Immunol (1974) 1.95
Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice. J Exp Med (1975) 1.94
Serum concentrations and allotypes of immunoglobulins in two lines of mice genetically selected for "high" or "low" antibody synthesis. J Exp Med (1970) 1.93
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev (2001) 1.87
The development of a risk-adjusted capitation payment system: the Maryland Medicaid model. J Ambul Care Manage (1998) 1.86
Clonal nature of the immune response to phosphorylcholine. I. Specificity, class, and idiotype of phosphorylcholine-binding receptors on lymphoid cells. J Exp Med (1974) 1.85
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res (2000) 1.84
Structure of human skeletal keratosulfate. The linkage region. J Biol Chem (1967) 1.77
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res (1996) 1.77
Horizontal and vertical disparity, eye position, and stereoscopic slant perception. Vision Res (1999) 1.75
Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci U S A (2005) 1.74
Association of H-2 types with genetic control of immune reponsiveness to IgG (gamma2a) allotypes in the mouse. J Exp Med (1972) 1.71
Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr (2000) 1.69
Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol (1975) 1.68
Separation of mammalian cells using programmed gradient sedimentation. Exp Mol Pathol (1969) 1.66
Isolation of plasma membrane fragments from HeLa cells. J Cell Biol (1969) 1.62
Idiotype of inulin-binding antibodies and myeloma proteins controlled by genes linked to the allotype locus of the mouse. J Immunol (1976) 1.62
Immune response to levan. I. Kinetics and ontogeny of anti-levan and anti-inulin antibody response and of expression of cross-reactive idiotype. J Immunol (1978) 1.57
Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst (1990) 1.56
Crossing over between genes in the immunoglobulin heavy chain linkage group of the mouse. J Exp Med (1969) 1.56
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci U S A (2000) 1.54
Mechanism of antidiuretic effect of beta adrenergic stimulation. J Clin Invest (1972) 1.54
Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev (1999) 1.49
Cytochalasin effects on BALB-3T3 fibroblasts: dose-dependent, reversible alteration of motility and cytoplasmic cleavage. Exp Cell Res (1971) 1.45
Density inhibition of motility in 3T3 fibroblasts and their SV40 transformants. Exp Cell Res (1971) 1.45
Isolation and characterization of viruses from fetal calf serum. In Vitro (1974) 1.43
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locus. J Immunol (1979) 1.43
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
Retinoids in chemoprevention and differentiation therapy. Carcinogenesis (2000) 1.38
The resolution of mixtures of viable mammalian cells into homogeneous fractions by zonal centrifugation. J Cell Biol (1968) 1.38
Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay. J Natl Cancer Inst (1972) 1.37
Quality control studies on fetal bovine serum used in tissue culture. In Vitro (1974) 1.37
Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads. Science (1975) 1.36
Immune response to levan. III. The capacity to produce anti-inulin antibodies and cross-reactive idiotypes appears late in ontogeny. J Immunol (1979) 1.34
Receptors for immunoglobulin and complement on mouse leukemias and lymphomas. J Immunol (1972) 1.31
Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit (1995) 1.30
Cell-substrate adhesivity. A determinant of cell motility. Exp Cell Res (1972) 1.29
Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys (1985) 1.28
Rate zonal centrifugation in a Ficoll gradient. Anal Biochem (1969) 1.28
Genetic factors controlling anti-sheep erythrocyte antibody response and immunoglobulin synthesis in backcross and F2 progeny of mice genetically selected for "high" or "low" antibody synthesis. J Exp Med (1972) 1.26
Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs. Toxicology (2009) 1.24
Effects of sublethal gamma radiation on T and B cell activity in the antibody response of mice. Radiat Res (1976) 1.23
Close linkage in genes controlling gamma-A and gamma-G heavy chain structure in BALB/c mice. J Mol Biol (1966) 1.22
Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res (1997) 1.17
Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis (2000) 1.14
Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res (1995) 1.14
Regulation of the anti-inulin antibody response by a nonallotype-linked gene. J Exp Med (1980) 1.14
How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc (2001) 1.13
Isoantibodies specific for myeloma gamma-G and gamma-H immunoglobulins of BALB-c mice. J Mol Biol (1966) 1.13
Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice. Carcinogenesis (2003) 1.13
Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res (1994) 1.12
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res (2000) 1.12
Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res (1999) 1.10
Cancer chemoprevention: progress and promise. Eur J Cancer (1999) 1.10
Genetic and cellular regulation of the expression of specific antibody idiotypes in the anti-polyfructosan immune response. Ann Immunol (Paris) (1979) 1.10
Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis (2001) 1.10
An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders. J Clin Pharmacol (1993) 1.09
Centrifugation of mammalian cells on gradients: a new rotor. Science (1968) 1.08
Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res (1997) 1.08
Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J Cell Biochem Suppl (1996) 1.08
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res (2000) 1.07
Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis (1999) 1.07
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev (2001) 1.07
2-chain immunoglobulin A molecules: abnormal or normal intermediates in synthesis. Science (1968) 1.06
Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev (1999) 1.06
Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis (2000) 1.06
Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis (1996) 1.06
Early stages of p53-induced apoptosis are reversible. Cell Death Differ (2001) 1.05
Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis (1994) 1.05
Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis (2000) 1.05